Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

NCT00608803 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alaunos Therapeutics